EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome

Katarzyna Lejman-Larysz, Anna Golara iD, Marta Baranowska, Mateusz Kozłowski iD, Paweł Guzik, Iwona Szydłowska iD, Jolanta Nawrocka-Rutkowska iD, Elżbieta Sowińska-Przepiera iD, Aneta Cymbaluk-Płoska, Agnieszka Brodowska iD

Nutrients · 2023

DOI: 10.3390/nu15132952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Katarzyna Lejman-Larysz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Po…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Metabolic Syndrome, Hyperandrogenism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder that affects 8–13% of women of reproductive age. It is one of the most common causes of infertility and is associated with hyperandrogenism in the form of hirsutism and acne, non-ovulatory cycles, and characteristic ovarian morphology. The available research on serum vitamin D deficiency in patients with PCOS and the appropriateness of vitamin D supplementation in this group of women is inconclusive, so we decided to investigate the influence of vitamin D on the incidence of metabolic syndrome and hormonal balance in patients with polycystic ovary syndrome. The study comprised 120 women aged between 18 and 42 years, who were divided into two groups: a group with diagnosed polycystic ovary syndrome (PCOS) and a group of regularly menstruating women without features of androgenisation, in whom polycystic ovary syndrome was excluded. Each patient underwent a history and physical examination, including a gynecological examination, anthropometric measurements were taken, including height, weight, waist, and hip circumference, and blood pressure was measured using the Korotkow method. In the female patients, the following parameters were also determined from the blood: follicle-stimulating hormone (FSH), luteinizing hormone (LH), oestradiol, TSH, ft4, prolactin (PRL), total testosterone, DHEASO4, 17-hydroxyprogesterone (17-OHP), sex-hormone-binding globulin (SHBG), androstendione, 25(OH) vitamin D3 metabolite. The majority of the patients with polycystic ovary syndrome were found to have deficient or suboptimal serum vitamin D levels, and the effects of vitamin D on the SHBG levels and free-androgen indices in these patients was examined. The effects of vitamin D on the incidence of metabolic syndrome and BMI, waist-to-hip ratio, waist circumference, and blood pressure in patients with polycystic ovary syndrome were also found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeMetabolic SyndromeHyperandrogenismFemaleHumansAdolescentYoung AdultAdultVitamin DIncidenceFollicle Stimulating HormoneTestosteroneVitamins

Stichwörter der Autor:innen

androstendionedehydroepiandrosterone sulfatefollicle-stimulating hormoneluteinizing hormonemetabolic syndromepolycystic ovary syndromeprolactinsex-hormone-binding globulinthyroid-stimulating hormonevitamin D

Substanzen

Vitamin DFollicle Stimulating HormoneTestosteroneVitamins

Autor:innen und Institutionen

  • Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Department of Reconstructive Surgery and Gynecological Oncology, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
  • Clinical Department of Gynecology and Obstetrics, City Hospital, 35-241 Rzeszów, Poland.
  • Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.

ORCID-Profile: Anna Golara, Mateusz Kozłowski, Iwona Szydłowska, Jolanta Nawrocka-Rutkowska, Elżbieta Sowińska-Przepiera, Agnieszka Brodowska

Zitieren

APA

Lejman-Larysz, K., Golara, A., Baranowska, M., Kozłowski, M., Guzik, P., Szydłowska, I., Nawrocka-Rutkowska, J., Sowińska-Przepiera, E., Cymbaluk-Płoska, A., & Brodowska, A. (2023). Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome. Nutrients. https://doi.org/10.3390/nu15132952

Vancouver

Lejman-Larysz K, Golara A, Baranowska M, Kozłowski M, Guzik P, Szydłowska I, et al. Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome. Nutrients. 2023. doi:10.3390/nu15132952

BibTeX
@article{LejmanLarysz2023,
  author = {Lejman-Larysz, Katarzyna and Golara, Anna and Baranowska, Marta and Kozłowski, Mateusz and Guzik, Paweł and Szydłowska, Iwona and Nawrocka-Rutkowska, Jolanta and Sowińska-Przepiera, Elżbieta and Cymbaluk-Płoska, Aneta and Brodowska, Agnieszka},
  title = {Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15132952}
}
Kostenlos starten →